BioSpace News Archive

Demand of advanced wound care will remain high in medical sector. This trend will continue due to the increasing cases of chronic and surgical wounds in the industry

Leap Therapeutics, Inc. announced the presentation of clinical data from its Phase 2 clinical trial of DKN-01 as a monotherapy and in combination with paclitaxel in patients with advanced gynecological malignancies at the Society of Gynecologic Oncology 2021 Annual Meeting on Women’s Cancer, being held as a virtual meeting from March 19-25, 2021.

Chime Biologics is pleased to announce the appointment of Marc Funk to its Board of Directors. Marc brings more than 20 years of leadership and industry experience in the global CDMO space.

Surgical retractors are primarily used to segregate the edges of a wound or a surgical incision to ensure that underlying organs and tissues remain untouched.

Lentiviral vectors find utilization as a medium to make a delivery of foreign genetic material into a separate cell. Making use of a type of retrovirus, a lentivirus, these vectors are produced.

First Phase III study to show that a cancer immunotherapy improves disease-free survival in people with resectable early stage lung cancer compared to best supportive care

Palm vein scanner refers to a biometric authentication device used for scanning vein patterns in the palm of an individual for authenticating the identity.

Eurofins Technologies announces the launch of its GSD NovaType II, its upgraded RT-PCR kit for the identification of mutations associated with SARS-CoV-2 variants of concern.

The Company receives a favorable opinion from the DMC on the safety of Sarconeos (BIO101) in the COVA study following first interim analysis

Yokogawa Electric Corporation (TOKYO:6841) announces the launch of Yokogawa Bio Frontier Inc. to develop businesses related to the production and sales of innovative plant-derived biomass materials, as well as associated licensing and consulting activities.